John E. Imhoff - 10 Feb 2023 Form 4 Insider Report for GUIDED THERAPEUTICS INC (GTHP)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: GTHP
Reported as of: 10 Feb 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 26 Jun 2023, 12:21:02 UTC
Prior SEC filing: 26 Jun 2023
Next SEC filing: 26 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/ John E. Imhoff

Key filing fact

John E. Imhoff filed Form 4 for GUIDED THERAPEUTICS INC (GTHP) on 26 Jun 2023.

Key facts

This page summarizes John E. Imhoff's Form 4 filing for GUIDED THERAPEUTICS INC (GTHP).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 26 Jun 2023, 12:21.

Change

Previous filing in this sequence was filed on 26 Jun 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GTHP transaction Derivative

Stock Options

Award

Transaction value
Shares: +100,000
Change %
Price
Shares after: 100,000
Date: 10 Feb 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 100,000
Exercise price: $0.2600
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

One-fourth of the shares subject to the award vested on February 10, 2023; the remaining shares will vest monthly, subject to the reporting person's continued service on each such date, until the award is fully vested on February 9, 2026.